Lotus Bio-Technology Development Corp.

FRC's fair value estimate for Lotus Bio-Technology Development Corp., and the rating behind it. LBTD last traded at $0.01; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Lotus Bio-Technology Development Corp.. Starting points for Lotus Bio-Technology Development Corp.: beta 1.76 — an Agricultural Inputs name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Lotus Bio-Technology Development Corp.. Lotus Bio-Technology Development Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Lotus Bio-Technology Development Corp.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Lotus Bio-Technology Development Corp.. Lotus Bio-Technology Development Corp. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Lotus Bio-Technology Development Corp. valued side by side against its closest peers. Lotus Bio-Technology Development Corp. is measured against Agricultural Inputs peers within the Basic Materials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Lotus Bio-Technology Development Corp., and how their positions are changing. At a $8.1M market value, institutional positions materially move Lotus Bio-Technology Development Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Lotus Bio-Technology Development Corp. executives and directors. Shares of Lotus Bio-Technology Development Corp. have traded between $0.01 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Lotus Bio-Technology Development Corp.. Lotus Bio-Technology Development Corp. is a $8.1M Basic Materials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Lotus Bio-Technology Development Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Lotus Bio-Technology Development Corp.. Coverage tracks Lotus Bio-Technology Development Corp. within Agricultural Inputs (Basic Materials). Press releases and market coverage, newest first.